30.45MMarket Cap
LossP/E TTM
Key Figures
0.660Open
0.680High
72.60KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.15%Turnover Ratio
0.672Prev. Close
0.650Low
38.09KTurnover
LossP/E Static
0.70P/B
0.00%Div Yield TTM
-107.86%ROA
2.93252wk High
1.78Volume Ratio
-32.01MNet Profit
46.84MShares
-0.6984EPS TTM
0.75Beta
-142.60%ROE
0.86452wk Low
4.45%Amplitude
20.22%Gross Margin
30.45MMarket Cap
-1.01Reward/Risk
3.86%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
InspireMD Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 118 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 3.67.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
InspireMD Inc Highlights
StrengthsRisks
InspireMD Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
InspireMD Inc Info
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Ticker SymbolNSPR
CompanyInspireMD Inc
CEOSlosman (Marvin L)
Websitehttps://www.inspiremd.com/en/
Shareholders
FAQs
What is the current price of InspireMD Inc (NSPR)?
The current price of InspireMD Inc (NSPR) is 0.65.
What is the symbol of InspireMD Inc?
The ticker symbol of InspireMD Inc is NSPR.
What is the 52-week high of InspireMD Inc?
The 52-week high of InspireMD Inc is 2.93.
What is the 52-week low of InspireMD Inc?
The 52-week low of InspireMD Inc is 0.86.
What is the market capitalization of InspireMD Inc?
The market capitalization of InspireMD Inc is 30.64M.
Is InspireMD Inc (NSPR) currently rated as Buy, Hold, or Sell?
According to analysts, InspireMD Inc (NSPR) has an overall rating of Buy, with a price target of 3.67.
What is the Earnings Per Share (EPS TTM) of InspireMD Inc (NSPR)?
The Earnings Per Share (EPS TTM) of InspireMD Inc (NSPR) is -0.76.
